Addis Ababa City Administration Health Bureau is recently implementing Provider Initiated HIVrnCounseling and Testing (PIHCT) in response to the high HIV prevalence among TB patients, and in anrnattempt to increase the uptake of HIV testing and ART. However, there has not been precise informationrnpertaining to the Voluntary counseling and testing (VCT) utilization status by tuberculosis (TB) patients.rnThis study was conducted in June 2006 to assess VCT utilization rate, perceived barriers for HIVrntesting, and willingness for PIHCT among TB patients in Addis Ababa.rnFacility-based, cross-sectional study was conducted and 423 TB patients interviewed. A stratified twornstage sampling method was used for the selection of study subjects. In the first stage of sampling, eightrnhealth centers were selected by simple random sampling. In the second stage of sampling, patientsrnwere systematically selected in each selected health center. The study had used quantitative andrnqualitative data collection methods.rnThe prevalence of self reported HIV testing among sampled TB patients was 57%. Adjusted correlatesrnof HIV testing include primary education (AOR=2.04, 95% CI=1.03-4.06), being merchant (AOR=5.67,rn95% CI=1.56-20.60), had moderate HIV risk perception (AOR=5.30, 95% CI=1.67-16.82), and high-HIVrnrisk perception (AOR=4.38, 95% CI=1.32-14.55). Patients who had willingness for PIHCT found morernlikely to have been tested for HIV (AOR=2.32, 95% CI=1.23-4.36).rnWhile experiences with client and provider-initiated HIV testing overall were positive, 86.2% of thernpatients were willing for PIHCT. The only adjusted correlates of willingness for PIHCT were being olderrnage group (AOR=4.16; 95% CI= 1.59-10.81), and had demand for HIV testing (AOR=29.13; 95% CIrn=13.83-61.32).rnvirnKey testing barriers include self trust (41.1%), lack of risk perception for HIV infection (24.4%), fear ofrnlearning positive result (13.9%), and stigma and discrimination attached to TB and HIV as identified inrnfocus group discussions.rnEarly evidence of widespread support for PIHCT and moderate acceptance of HIV testing in this studyrnholds significant promise for the control, prevention and treatment of HIV/AIDS and TB. Concertedrnefforts to scale up PIHCT, however, must be accompanied by intensive IEC on TB /HIV along withrntackling of testing barriers.